Find paid trials
Partner with us

Leadership & Governance

Leadership & Governance

Linear Clinical Research is led by experts committed to advancing medical science through ethical, high-quality clinical trials that improve lives worldwide.

Linear-260331-Board-01-scaled

Leadership & Governance

Linear Clinical Research is led by experts committed to advancing medical science through ethical, high-quality clinical trials that improve lives worldwide.

The Linear Team

Roger Port

Chair

About Roger

Peter Leedman AO

Board Member

About Peter

Anita van der Meer

Board Member

About Anita

Fiona Harris

Board Member

About Fiona

Nina Webster

Board Member

About Nina

Mark Potts

Board Member

About Mark

Professor Chan Cheah

Medical Director Haematology

About Chan

Professor Michael Millward

Medical Director Oncology

About Michael

Jayden Rogers

CEO

About Jayden

Dr Lara Hatchuel

Medical Director Early Phase Unit

About Lara

Simon Martin

Chief Financial Officer

About Simon

Genevieve Cameron

Chief People, Culture & Transformation Officer

About Genevieve

Zelda Herbst

Director of Cancer Trials

About Zelda

Simon Scott

Director Early Phase

About Simon

Roger Port

Chair

About Roger

Anita van der Meer

Board Member

About Anita

Peter Leedman AO

Board Member

About Peter

Mark Potts

Board Member

About Mark

Fiona Harris

Board Member

About Fiona

Jayden Rogers

CEO

About Jayden

Simon Scott

Director Early Phase

About Simon

Zelda Herbst

Director of Cancer Trials

About Zelda

Professor Michael Millward

Medical Director Oncology

About Michael

Dr Lara Hatchuel

Medical Director Early Phase Unit

About Lara

Genevieve Cameron

Chief People, Culture & Transformation Officer

About Genevieve

Professor Chan Cheah

Medical Director Haematology

About Chan

Simon Martin

Chief Financial Officer

About Simon

Ryan Kafoure

Chief Business Development Officer

About Ryan

Roger Port

Chair

About Roger

Anita van der Meer

Board Member

About Anita

Peter Leedman AO

Board Member

About Peter

Mark Potts

Board Member

About Mark

Fiona Harris

Board Member

About Fiona

Jayden Rogers

CEO

About Jayden

Simon Scott

Director Early Phase

About Simon

Zelda Herbst

Director of Cancer Trials

About Zelda

Professor Michael Millward

Medical Director Oncology

About Michael

Dr Lara Hatchuel

Medical Director Early Phase Unit

About Lara

Genevieve Cameron

Chief People, Culture & Transformation Officer

About Genevieve

Professor Chan Cheah

Medical Director Haematology

About Chan

Simon Martin

Chief Financial Officer

About Simon

Ryan Kafoure

Chief Business Development Officer

About Ryan

Latest News

Stay informed with updates from Linear Clinical Research, including insights into Australian clinical trials, medical innovations, and stories from our research community.

06 May, 2026

Our impact that drives us

Read Blog

06 May, 2026

Advancing Treatment for RareCholesterol Disorders – HomozygousFamilial Hypercholesterolemia (HoFH)

Read Blog

13 July, 2026

World-Leading Cancer Clinical Trial Centre Opens in WA, Giving Patients Access to Breakthrough Treatments

Read Blog
View all Blogs

Governance
and Ethics

Learn About Linear

Linear Clinical Research operates under the oversight of an experienced Board of Directors and independent ethics committees. Every trial is conducted in accordance with Good Clinical Practice (GCP) and approved by committees registered with the National Health and Medical Research Council (NHMRC).

This governance framework ensures that all studies meet the highest international standards for safety, data integrity, and participant wellbeing.

Roger Port

Chair

Roger is currently the chair of Linear Clinical Research Limited and a non-executive director of CTI Logistics Limited (ASX:CLX), Eagle Mountain Mining (ASX:EM2) and Cullen Wines (Australia) Pty Ltd. He has held a number of non-executive director roles over the past 25 years including in the health and medical research, aged care and education sectors, including as a board member of the Harry Perkins Institute of Medical Research from 2015 to 2024. Roger was a partner of PricewaterhouseCoopers for 19 years up to his retirement from the firm in 2016. He has extensive experience in financial analysis, company and business valuations, transaction due diligence and mergers and acquisitions across a range of industries and led the PwC Perth Deals team for seven years. He is a graduate of Macquarie University and a Fellow of Chartered Accountants Australia and New Zealand, a Fellow of the Australian Institute of Company Directors and a former Senior Fellow of the Financial Services Institute of Australia.

Leadership & Governance

Peter is a current Director and the inaugural and Past-Chair of Linear Clinical Research (Linear), a wholly owned subsidiary of the Harry Perkins Institute of Medical Research (Perkins) and has been involved with Linear since its inception.

He is the Chief Executive Officer and Director of the Perkins and a Professor of Medicine at University of Western Australia (UWA). He graduated in medicine from UWA then undertook specialist training in endocrinology at Royal Melbourne Hospital in the 90s. He completed PhD studies at the Walter and Eliza Hall Institute of Medical Research and postdoctoral studies at Harvard Medical School, before returning to Perth.

Peter is internationally recognised for his RNA-based research on hormone-dependent cancers (breast and prostate) and more lately on poor prognostic tumours (liver, head and neck cancer). As Laboratory Head of Cancer Medicine at the Perkins, he and his team are developing microRNA-based therapies for these solid tumours that are being translated to the bedside.

Peter is a Board Member of the national Association of Australian Medical Research Institutes, fellow of the Australian Academy of Health and Medical Sciences, a Graduate of the Australian Institute of Company Directors and co-founder of miReven, a biotech company focused on developing a novel way to treat liver cancer with micro RNA’s. Peter was appointed an Officer of the Order of Australia in the Australia Day 2021 Honours List for distinguished service to medicine, health and medical research as a physician scientist, to professional societies, and to tertiary education.